| Section | Status | CDF | Name |
| 08.03.04.02 | Formulary |  |
Abiraterone acetate Zytiga® |
| 08.01.05 | Formulary | |
Alectinib hydrochloride Alecensa® |
| 08.01.05 | Formulary | |
Arsenic trioxide Trisenox® |
| 08.01.05 | Formulary | |
Atezolizumab Tecentriq® |
| 08.01.05 | Formulary | |
Avelumab Bavencio® |
| 08.02.04 | Formulary | |
Axicabtagene ciloleucel Yescarta® |
| 08.01.01 | Formulary | |
Bendamustine hydrochloride |
| 08.02.03 | Formulary | |
Blinatumomab Blincyto® |
| 08.01.05 | Formulary | |
Bortezomib Velcade® |
| 08.01.05 | Formulary | |
Bosutinib Bosulif® |
| 08.01.05 | Formulary | |
Brentuximab vedotin Adcetris® |
| 08.01.05 | Formulary | |
Cabazitaxel Jevtana® |
| 08.01.05 | Formulary | |
Cabozantinib Cabometyx® |
| 08.01.05 | Formulary | |
Carfilzomib Kyprolis® |
| 08.01.05 | Formulary | |
Cemiplimab Libtayo® |
| 08.01.05 | Formulary | |
Ceritinib Zykadia® |
| 08.01.05 | Formulary | |
Cetuximab Erbitux® |
| 08.01.05 | Formulary | |
Crizotinib Xalkori® |
| 08.01.05 | Formulary | |
Dabrafenib mesilate Tafinlar® |
| 08.01.05 | Formulary | |
Daratumumab Darzalex® |
| 08.03.04.02 | Formulary | |
Darolutamide Nubeqa® |
| 08.01.05 | Formulary | |
Dasatinib Sprycel® |
| 08.01.05 | Formulary | |
Dinutuximab beta Qarziba® |
| 08.01.05 | Formulary | |
Doxorubicin hydrochloride Caelyx® |
| 08.01.05 | Formulary | |
Entrectinib Rozlytrek® |
| 08.03.04.02 | Formulary | |
Enzalutamide Xtandi® |
| 08.01.05 | Formulary | |
Eribulin Halaven® |
| 08.01.05 | Formulary | |
Gemtuzumab ozogamicin Mylotarg® |
| 08.01.05 | Formulary | |
Gilteritinib Xospata® |
| 08.01.05 | Formulary | |
Ibrutinib Imbruvica® |
| 08.01.05 | Formulary | |
Inotuzumab ozogamicin Besponsa® |
| 08.01.05 | Formulary | |
Ipilimumab Yervoy® |
| 08.01.05 | Formulary | |
Isatuximab Sarclisa® |
| 08.01.05 | Formulary | |
Ixazomib Ninlaro® |
| 08.01.05 | Formulary | |
Larotrectinib |
| 08.02.04 | Formulary | |
Lenalidomide Revlimid® |
| 08.01.05 | Formulary | |
Lenvatinib |
| 08.01.05 | Formulary | |
Lorlatinib Lorviqua® |
| 08.03.04.03 | Formulary | |
Lutetium (177Lu) oxodotreotide |
| 08.01.05 | Formulary | |
Midostaurin Rydapt ® |
| 08.01.05 | Formulary | |
Nilotinib Tasigna® |
| 08.01.05 | Formulary | |
Niraparib Zejula® |
| 08.01.05 | Formulary | |
Nivolumab Opdivo® |
| 08.02.03 | Formulary | |
Obinutuzumab Gazyvaro® |
| 08.01.05 | Formulary | |
Olaparib Lynparza® |
| 08.01.05 | Formulary | |
Olaratumab Lartruvo® |
| 08.01.05 | Formulary | |
Osimertinib Tagrisso® |
| 08.01.05 | Formulary | |
Palbociclib Ibrance® |
| 08.01.05 | Formulary | |
Panitumumab Vectibix® |
| 08.01.05 | Formulary | |
Panobinostat Farydak® |
| 08.01.05 | Formulary | |
Pembrolizumab Keytruda® |
| 08.01.03 | Formulary | |
Pemetrexed disodium Alimta® |
| 08.01.05 | Formulary | |
Pertuzumab Perjeta® |
| 08.01.05 | Formulary | |
Polatuzumab vedotin Polivy® |
| 08.02.04 | Formulary | |
Pomalidomide Imnovid® |
| 08.01.05 | Formulary | |
Ponatinib Iclusig® |
| 08.01.05 | Formulary | |
Regorafenib Stivarga® |
| 08.01.05 | Formulary | |
Ribociclib succinate Kisqali® |
| 08.02.04 | Formulary | |
Rucaparib Rubraca® |
| 08.01.05 | Formulary | |
Ruxolitinib phosphate Jakavi® |
| 08.01.05 | Formulary | |
Sunitinib Sutent® |
| 08.01.05 | Formulary | |
Talimogene laherparepvac Imlygic® |
| 08.01.05 | Formulary | |
Tisagenlecleucel Kymriah® |
| 08.01.05 | Formulary | |
Tivozanib Fotivda® |
| 08.01.05 | Formulary | |
Trametinib Mekinist® |
| 08.01.05 | Formulary | |
Trastuzumab |
| 08.01.05 | Formulary | |
Trastuzumab emtansine |
| 08.01.05 | Formulary | |
Trifluridine-tipiracil Lonsurf® |
| 08.01.05 | Formulary | |
Venetoclax Venclyxto® |